Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Judges Wade Into Abortion Pill Access And Rx Pricing Fights No Photo Available

Hannah Albarazi

In a flurry of recent legal activity, courts across the country have been drawn into the nation's most contentious healthcare debates ... (more story)

Defining The 'Superior' Bid In Pfizer-Novo Legal Battle No Photo Available

Yeji Jesse Lee

Pfizer and Novo Nordisk's bidding war and legal fight over obesity biotech company Metsera is raising questions around what legally co... (more story)

Meet The Attys Behind Drugmakers' Conn. Price Cap Suit No Photo Available

Gianna Ferrarin

Attorneys from Goodwin Procter LLP and Wiggin and Dana LLP are teaming up to represent the Association for Accessible Medicines in its... (more story)